![IJMS | Free Full-Text | Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer | HTML IJMS | Free Full-Text | Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer | HTML](https://www.mdpi.com/ijms/ijms-23-13235/article_deploy/html/images/ijms-23-13235-g004.png)
IJMS | Free Full-Text | Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer | HTML
![Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352304220301628-gr1.jpg)
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse surv
![Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations. - ppt download Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations. - ppt download](https://slideplayer.com/slide/15027409/91/images/12/Case+1%3A+48-Year-Old+Woman+Diagnosed+With+Recurrent+ER%2FPR-Positive%2C+HER2-Positive+Breast+Cancer+%28cont%29.jpg)
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations. - ppt download
![Prognostic significance of Substance P/ Neurokinin 1 receptor and its association with hormonal receptors in breast carcinoma | bioRxiv Prognostic significance of Substance P/ Neurokinin 1 receptor and its association with hormonal receptors in breast carcinoma | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/09/03/2020.06.27.175083/F2.medium.gif)
Prognostic significance of Substance P/ Neurokinin 1 receptor and its association with hormonal receptors in breast carcinoma | bioRxiv
![Texas Soc of Pathol on Twitter: "Breast Mucinous Carcinoma: Micropapillary pattern: Clusters of tumor cells, intermediate to high grade nuclei, HER2 positive, worse prognosis Positive for ER, PR, MUC2, GATA3, and NE Texas Soc of Pathol on Twitter: "Breast Mucinous Carcinoma: Micropapillary pattern: Clusters of tumor cells, intermediate to high grade nuclei, HER2 positive, worse prognosis Positive for ER, PR, MUC2, GATA3, and NE](https://pbs.twimg.com/media/E_-AxAMXIAMibjx.jpg:large)
Texas Soc of Pathol on Twitter: "Breast Mucinous Carcinoma: Micropapillary pattern: Clusters of tumor cells, intermediate to high grade nuclei, HER2 positive, worse prognosis Positive for ER, PR, MUC2, GATA3, and NE
![IJMS | Free Full-Text | Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer | HTML IJMS | Free Full-Text | Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer | HTML](https://www.mdpi.com/ijms/ijms-23-13235/article_deploy/html/images/ijms-23-13235-g003.png)
IJMS | Free Full-Text | Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer | HTML
Association between ultrasound findings, tumor type, grade, and biological markers in patients with breast cancer
Representative images of IHC for the markers of IDC tested in breast... | Download Scientific Diagram
![Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer | British Journal of Cancer Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01514-7/MediaObjects/41416_2021_1514_Fig1_HTML.png)
Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer | British Journal of Cancer
![Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium | Breast Cancer Research | Full Text Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium | Breast Cancer Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fbcr3663/MediaObjects/13058_2013_3419_Fig3_HTML.jpg)
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium | Breast Cancer Research | Full Text
![De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ±](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e1c0e775-3ab7-4656-b207-798ee2292951/gr1.jpg)
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ±
![Breast Cancer Tissue Markers, Genomic Profiling, and Other Prognostic Factors: A Primer for Radiologists | RadioGraphics Breast Cancer Tissue Markers, Genomic Profiling, and Other Prognostic Factors: A Primer for Radiologists | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2018180047/asset/images/medium/rg.2018180047.fig13.gif)
Breast Cancer Tissue Markers, Genomic Profiling, and Other Prognostic Factors: A Primer for Radiologists | RadioGraphics
![Breast Cancer Tissue Markers, Genomic Profiling, and Other Prognostic Factors: A Primer for Radiologists | RadioGraphics Breast Cancer Tissue Markers, Genomic Profiling, and Other Prognostic Factors: A Primer for Radiologists | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2018180047/asset/images/medium/rg.2018180047.tbl1.gif)
Breast Cancer Tissue Markers, Genomic Profiling, and Other Prognostic Factors: A Primer for Radiologists | RadioGraphics
![Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1332ad61-1612-4599-87d3-f24b3014c44f/ijc33969-toc-0001-m.jpg)
Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library
![The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases | Anticancer Research The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/1/313/F1.large.jpg)
The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases | Anticancer Research
![a) Nuclear positive staining for ER; (b) nuclear positive staining for... | Download Scientific Diagram a) Nuclear positive staining for ER; (b) nuclear positive staining for... | Download Scientific Diagram](https://www.researchgate.net/publication/239943663/figure/fig1/AS:202649422045196@1425326795256/a-Nuclear-positive-staining-for-ER-b-nuclear-positive-staining-for-PgR-c-membrane.png)
a) Nuclear positive staining for ER; (b) nuclear positive staining for... | Download Scientific Diagram
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration | PLOS Medicine
![Progesterone receptor (PR) Immuno-histochemical marker x100 showing... | Download Scientific Diagram Progesterone receptor (PR) Immuno-histochemical marker x100 showing... | Download Scientific Diagram](https://www.researchgate.net/publication/362073424/figure/fig1/AS:1179178560954368@1658149485056/Progesterone-receptor-PR-Immuno-histochemical-marker-x100-showing-moderate-nuclear.png)